Renaissance Technologies’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.77M | Buy |
615,100
+451,000
| +275% | +$2.03M | ﹤0.01% | 1906 |
|
|
2025
Q1 | $761K | Sell |
164,100
-81,600
| -33% | -$379K | ﹤0.01% | 2562 |
|
|
2024
Q4 | $1.71M | Buy |
245,700
+27,000
| +12% | +$187K | ﹤0.01% | 2155 |
|
|
2024
Q3 | $1.16M | Sell |
218,700
-36,014
| -14% | -$191K | ﹤0.01% | 2352 |
|
|
2024
Q2 | $953K | Buy |
254,714
+132,614
| +109% | +$496K | ﹤0.01% | 2351 |
|
|
2024
Q1 | $861K | Buy |
122,100
+16,900
| +16% | +$119K | ﹤0.01% | 2572 |
|
|
2023
Q4 | $594K | Buy |
105,200
+13,700
| +15% | +$77.4K | ﹤0.01% | 2709 |
|
|
2023
Q3 | $438K | Buy |
91,500
+9,700
| +12% | +$46.4K | ﹤0.01% | 2769 |
|
|
2023
Q2 | $560K | Buy |
81,800
+53,900
| +193% | +$369K | ﹤0.01% | 2813 |
|
|
2023
Q1 | $217K | Buy |
27,900
+11,500
| +70% | +$89.4K | ﹤0.01% | 3244 |
|
|
2022
Q4 | $125K | Buy |
+16,400
| New | +$125K | ﹤0.01% | 3559 |
|